Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD Kun-Ta Chou, Kang-Cheng Su, Yi-Han Hsiao, Shiang-Fen Huang, Hsin-Kuo Ko, Ching-Min Tseng, Vincent Yi-Fong Su, Diahn-Warng Perng

The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort Diana Betancor, Carlos Villalobos-Vilda, José María Olaguibel, José Manuel Rodrigo-Muñoz, María Jose Alvarez Puebla, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Victoria Del Pozo, Javier Domínguez-Ortega, Francisco-Javier González-Barcala, Juan Alberto Luna-Porta, Carlos Martínez-Rivera, Joaquim Mullol, Xavier Muñoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Joaquín Sastre

Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study Mònica Monteagudo, Alexa Nuñez, Miriam Barrecheguren, Marc Miravitlles